Scinovex
review Open AccessTop 1% cited

Neuropathic pain: an updated grading system for research and clinical practice

Pain · 2016 · Vol. 157(8) · pp. 1599–1606
Nanna Brix FinnerupSimon HaroutounianPeter KamermanRalf BaronDavid BennettDidier BouhassiraG. CruccuRoy FreemanPer HanssonTuro NurmikkoSrinivasa N. RajaAndrew S.C. RiceJordi SerraBlair H. SmithRolf‐Detlef TreedeTroels S. Jensen

Abstract

The redefinition of neuropathic pain as "pain arising as a direct consequence of a lesion or disease affecting the somatosensory system," which was suggested by the International Association for the Study of Pain (IASP) Special Interest Group on Neuropathic Pain (NeuPSIG) in 2008, has been widely accepted. In contrast, the proposed grading system of possible, probable, and definite neuropathic pain from 2008 has been used to a lesser extent. Here, we report a citation analysis of the original NeuPSIG grading paper of 2008, followed by an analysis of its use by an expert panel and recommendations for an improved grading system. As of February, 2015, 608 eligible articles in Scopus cited the paper, 414 of which cited the neuropathic pain definition. Of 220 clinical studies citing the paper, 56 had used the grading system. The percentage using the grading system increased from 5% in 2009 to 30% in 2014. Obstacles to a wider use of the grading system were identified, including (1) questions about the relative significance of confirmatory tests, (2) the role of screening tools, and (3) uncertainties about what is considered a neuroanatomically plausible pain distribution. Here, we present a revised grading system with an adjusted order, better reflecting clinical practice, improvements in the specifications, and a word of caution that even the "definite" level of neuropathic pain does not always indicate causality. In addition, we add a table illustrating the area of pain and sensory abnormalities in common neuropathic pain conditions and propose areas for further research.

Pain Mechanisms and TreatmentsBotulinum Toxin and Related Neurological DisordersMusculoskeletal pain and rehabilitationNeuropathic painGrading (engineering)MedicineClinical PracticePhysical therapyAnesthesia

MeSH terms

HumansNeuralgiaPain MeasurementSurveys and QuestionnairesResearchPain Management

Funding

  • Eli Lilly and Company
  • Pfizer
  • AstraZeneca
  • Sanofi
  • International Association for the Study of Pain
  • Teva Pharmaceutical Industries
  • Glenmark Pharmaceuticals
  • European Commission
  • Deutsche Forschungsgemeinschaft
  • Bundesministerium für Bildung und Forschung
  • Eisai
  • Novo Nordisk
  • Astellas Pharma
  • Novo Nordisk Fonden
  • Allergan
  • Sanofi Pasteur
  • National Institute of General Medical Sciences
  • Daiichi Sankyo Europe
Citations
1,218
FWCI
55.89
field-weighted impact
References
34
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.